4th Quarter - Report
BURRELL INTERNATIONAL GROUP LLC for EMERGENT BIOSOLUTIONS INC (F/K/A ADAPT PHARMA INC )
Income
$10,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Opioid and heroin addiction legislation, Naloxone access.
Foreign entity interest: Adapt Pharma is a U.S. domestic subsidiary of a foreign parent. All lobbying efforts, while not controlled, supervised, or directed by the parent, benefit the parent tangentially.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN BURRELL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.